Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EZFL | Common Stock | Purchase | $45.6K | +20.3K | +27.47% | $2.25 | 94K | Dec 2, 2021 | Direct | F1 |
transaction | EZFL | Common Stock | Purchase | $569 | +254 | +0.27% | $2.24 | 94.3K | Dec 2, 2021 | Direct | F2 |
transaction | EZFL | Common Stock | Purchase | $3.47K | +1.52K | +1.62% | $2.28 | 95.8K | Dec 2, 2021 | Direct | F3 |
transaction | EZFL | Common Stock | Purchase | $39.2K | +18K | +18.79% | $2.18 | 114K | Dec 3, 2021 | Direct | F4 |
holding | EZFL | Common Stock | 186K | Dec 2, 2021 | Cameo Life Sciences Investments LLC | F5 |
Id | Content |
---|---|
F1 | The 20,263 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife. |
F2 | The 254 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife. |
F3 | The 1,523 shares the Reporting Person purchased on December 2, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife. |
F4 | The 18,000 shares the Reporting Person purchased on December 3, 2021 are held by Jack Levine and Susan Levine JTWROS, a joint tenant account of the Reporting Person and his wife. |
F5 | Jack Levine is the Manager of Cameo Life Sciences Investments LLC and beneficially owns 186,010 shares of common stock, which are held by Cameo Life Sciences Investments, LLC. |